John F. Gerecitano, MD, PhD

John F. Gerecitano, MD, PhD

I am a medical oncologist/hematologist who cares for patients with lymphoma. I have clinical expertise in both Hodgkin and non-Hodgkin lymphoma. My research interests focus on finding new treatments for patients with lymphoma. To accomplish this goal, I serve as the principal investigator on several phase I and phase II clinical trials aimed at bringing promising new treatments from laboratories around the world into early clinical trials. Many of my trials explore innovative ways to combine existing drugs with newer treatments in order to find novel ways to advance the care of patients with lymphoma. I am also a member of the Developmental Therapeutics Group — a team of medical oncologists dedicated to providing access to the newest phase I agents for patients with all types of cancer throughout the Memorial Sloan Kettering system.

Location
Appointments for New Patients
646-497-9137
Phone
212-639-3748
Clinical Expertise

Hodgkin and Non-Hodgkin Lymphomas; Clinical Trials and New Drug Development in Lymphoma and Solid Tumors

Languages Spoken
English
Education

MD, PhD, New York University School of Medicine

Residencies

Hospital of the University of Pennsylvania

Fellowships

Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine; Medical Oncology

See My Colleagues in:
Clinical Trials Co-Investigated by John F. Gerecitano
Publications by John F. Gerecitano
Visit PubMed for full listing of John F. Gerecitano journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.